Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13
Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13
Effective treatment for severe corticosteroid refractory asthma is a significant unmet clinical need. It affects only a small percent of the asthmatic population but accounts for a disproportionate use of healthcare resources. The aim was to study IL-13 transgenic mice to test the hypothesis that a subset of IL-13 mediated airway responses are corticosteroid-unresponsive and contribute to ongoing airways symptoms.
IL-13 expression in the lungs was induced using Doxycycline in Ccsp-rtTA/Otet-Il-13 (Ccsp/Il-13) mice. Where indicated, mice received intra-peritoneal injections of 3mg/kg Dexamethasone for 3-7 days. Lungs were analysed for airway hyperreactivity and inflammation.
Compared to controls, Ccsp/Il-13 mice showed significantly increased airway hyperresponsiveness (AHR) to methacholine and immunohistochemistry revealed increased bronchial smooth muscle and goblet cell metaplasia. The bronchoalveolar lavage fluid contained mixed eosinophilic and neutrophilic inflammation, but neutrophils predominated. Characteristic Th2-responsive genes as well as genes associated with Th17 responses were significantly elevated. Treatment with steroids did not abrogate AHR, even though eosinophilia and the ‘Th2’ gene signature were significantly reduced. Neutrophils and the ‘Th17’ signature remained elevated.
Although IL-13 promotes eosinophilic airways disease, it can also drive corticosteroid refractory inflammation characterised by persistent neutrophilia, Th17 cytokines and maintenance of AHR. The Ccsp/Il-13 mouse may be a useful model for dissecting the molecular pathways and mechanisms associated with predominant neutrophilic, corticosteroid refractory airway disease.
Corticosteroid resistance, Neutrophilic, airway inflammation, airway hyperresponsiveness, IL-13
111 PA973
Davies, Elizabeth R
aff6b3f7-91e0-4fd3-9554-a9389024b63b
Kelly, Joanne, Freda Carmichael
5950d431-bc7e-4bad-817b-77446fc7332e
Whitsett, Jeffrey A.
84fb8fc3-212e-4741-8934-d4083cd6549b
Davies, Donna E
7de8fdc7-3640-4e3a-aa91-d0e03f990c38
Haitchi, Hans Michael
68dadb29-305d-4236-884f-e9c93f4d78fe
16 September 2018
Davies, Elizabeth R
aff6b3f7-91e0-4fd3-9554-a9389024b63b
Kelly, Joanne, Freda Carmichael
5950d431-bc7e-4bad-817b-77446fc7332e
Whitsett, Jeffrey A.
84fb8fc3-212e-4741-8934-d4083cd6549b
Davies, Donna E
7de8fdc7-3640-4e3a-aa91-d0e03f990c38
Haitchi, Hans Michael
68dadb29-305d-4236-884f-e9c93f4d78fe
Davies, Elizabeth R, Kelly, Joanne, Freda Carmichael, Whitsett, Jeffrey A., Davies, Donna E and Haitchi, Hans Michael
(2018)
Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13.
European Respiratory Society (ERS) International Congress 2018, , Paris, France.
15 - 19 Sep 2018.
.
Record type:
Conference or Workshop Item
(Poster)
Abstract
Effective treatment for severe corticosteroid refractory asthma is a significant unmet clinical need. It affects only a small percent of the asthmatic population but accounts for a disproportionate use of healthcare resources. The aim was to study IL-13 transgenic mice to test the hypothesis that a subset of IL-13 mediated airway responses are corticosteroid-unresponsive and contribute to ongoing airways symptoms.
IL-13 expression in the lungs was induced using Doxycycline in Ccsp-rtTA/Otet-Il-13 (Ccsp/Il-13) mice. Where indicated, mice received intra-peritoneal injections of 3mg/kg Dexamethasone for 3-7 days. Lungs were analysed for airway hyperreactivity and inflammation.
Compared to controls, Ccsp/Il-13 mice showed significantly increased airway hyperresponsiveness (AHR) to methacholine and immunohistochemistry revealed increased bronchial smooth muscle and goblet cell metaplasia. The bronchoalveolar lavage fluid contained mixed eosinophilic and neutrophilic inflammation, but neutrophils predominated. Characteristic Th2-responsive genes as well as genes associated with Th17 responses were significantly elevated. Treatment with steroids did not abrogate AHR, even though eosinophilia and the ‘Th2’ gene signature were significantly reduced. Neutrophils and the ‘Th17’ signature remained elevated.
Although IL-13 promotes eosinophilic airways disease, it can also drive corticosteroid refractory inflammation characterised by persistent neutrophilia, Th17 cytokines and maintenance of AHR. The Ccsp/Il-13 mouse may be a useful model for dissecting the molecular pathways and mechanisms associated with predominant neutrophilic, corticosteroid refractory airway disease.
This record has no associated files available for download.
More information
Published date: 16 September 2018
Venue - Dates:
European Respiratory Society (ERS) International Congress 2018, , Paris, France, 2018-09-15 - 2018-09-19
Keywords:
Corticosteroid resistance, Neutrophilic, airway inflammation, airway hyperresponsiveness, IL-13
Identifiers
Local EPrints ID: 428127
URI: http://eprints.soton.ac.uk/id/eprint/428127
PURE UUID: f0904e0d-48ff-429b-adb5-989ca35f4640
Catalogue record
Date deposited: 12 Feb 2019 17:30
Last modified: 16 Mar 2024 04:02
Export record
Contributors
Author:
Joanne, Freda Carmichael Kelly
Author:
Jeffrey A. Whitsett
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
